SanBio
1 known investors
Find your way into SanBio
Sign up to see every warm intro you have to SanBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SanBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SanBio develops regenerative cell-based medicines for patients with neurological conditions, with its lead product SB623 used for chronic motor paralysis following traumatic brain injury. Its approved product is marketed in Japan as an intracerebral implant injection.
Founders & leadership
Investors · 1
Frequently asked questions
- What does SanBio do?
- SanBio develops regenerative cell-based medicines for patients with neurological conditions, with its lead product SB623 used for chronic motor paralysis following traumatic brain injury. Its approved product is marketed in Japan as an intracerebral implant injection.
- Who founded SanBio?
- SanBio was founded by Toru Kawanishi.
- Who are SanBio's investors?
- SanBio's investors include Western Technology Investment.
